đź“‹ FDA Reference
modified ham s f-10 basal medium modified hams s f-10 basal medium hepes modified ham s f-10 supplement 50x iyophili
Irvine Scientific Sales
Summary: The Modified Ham's F-10 Basal Medium is a culture medium used in laboratory settings, primarily by clinicians and researchers for cell culture applications. It is utilized in various medical and research laboratories.
FDA Clearance Information
Pathway
510K
Number
K991419 ↗
Decision Date
September 14, 1999
Product Code
MQL
Device Class
Class 2
Evidence
419 studies
The Modified Ham's F-10 Basal Medium by Irvine Scientific was cleared through the FDA 510(k) pathway on September 14, 1999. It is classified as a Class 2 medical device under product code MQL.
What It Is
This device is a modified version of Ham's F-10 Basal Medium, a nutrient-rich solution used to support the growth and maintenance of cells in culture. It is often supplemented with additional components like HEPES buffer to stabilize pH levels. The medium provides essential nutrients, vitamins, and minerals necessary for cell survival and proliferation in vitro.
Clinical Applications
The Modified Ham's F-10 Basal Medium is commonly used in research and clinical laboratories that focus on cell culture techniques. It is essential for various applications, including embryology, oncology research, and tissue engineering. Clinicians and researchers in fields such as reproductive medicine and cancer research frequently use this medium to cultivate and study cell lines.
Indications for Use
The FDA indications suggest that this medium is intended for use in cell culture applications, providing a controlled environment for the growth and maintenance of cells. It is suitable for a range of cell types and is often used in research settings to study cellular processes.
Practical Considerations
When using this medium, consider compatibility with specific cell lines and any additional supplements that may be required for optimal growth. It is typically available in various formulations and concentrations, allowing customization based on experimental needs.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Modified Ham's F-10 Basal Medium used for?
It is used for supporting the growth and maintenance of cells in culture, providing essential nutrients and a stable environment.
What specialties typically use this device?
Specialties such as reproductive medicine, oncology research, and tissue engineering commonly use this medium.
What are the FDA-cleared indications?
The medium is indicated for use in cell culture applications, providing a nutrient-rich environment for various cell types.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.